SCHEMBL20174022

SCHEMBL20174022

C[C@]1(C(=O)O)C[C@H](O)CC([C@H](O)CN)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20173804 0.87 L3MBTL1 (0.34) —
SCHEMBL13367191 0.78 L3MBTL1 (0.43) —
SCHEMBL18313722 0.78 L3MBTL1 (0.43) —
SCHEMBL20174026 0.73 L3MBTL1 (0.33) —
SCHEMBL20173782 0.73 L3MBTL1 (0.33) —
SCHEMBL18463688 0.73 L3MBTL1 (0.33) —
SCHEMBL23969111 0.69 — —
SCHEMBL20173248 0.67 L3MBTL1 (0.43) —
SCHEMBL20173252 0.67 L3MBTL1 (0.43) —
SCHEMBL22023539 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11199542-B2 Method for labeling specifically living bacteria comprising the use of modified non endogenous monosaccharide compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2021-12-14 — — US disclosed
US-20180143193-A1 METHOD FOR LABELING SPECIFICALLY LIVING BACTERIA COMPRISING THE USE OF MODIFIED NON ENDOGENOUS MONOSACCHARIDE COMPOUNDS UNIVERSITE D'AIX-MARSEILLE (FR) 2018-05-24 — — US disclosed
Send feedback